Predicting the risk of frequent exacerbations in patients with chronic obstructive pulmonary disease
https://doi.org/10.36604/1998-5029-2025-98-68-74
Abstract
Aim. To study the possibility of predicting frequent exacerbations of chronic obstructive pulmonary disease (COPD) by assessing parameters of lung function and echocardiographic indices.
Materials and methods. A oneyear prospective single-center study included 85 patients with COPD exacerbations, of whom two groups were formed based on the results of observation during the year. Group 1 included patients (n = 28) with one or no exacerbations per year, group 2 included patients (n = 57) with two or more exacerbations during the year (frequent exacerbations). It was found that patients in group 2 had more pronounced impairments of lung and cardiac function. A comprehensive clinical and functional examination included the CAT, mMRC, KOP-25 questionnaires, a study of lung function and an echocardiographic examination.
Results. Based on discriminant analysis data, two highly effective prediction models were developed to identify patients at increased risk of frequent exacerbations over the course of a year. Questionnaire results, respiratory parameters (FEV1, FEF50), and echocardiographic parameters (interventricular septal thickness and tricuspid annular systolic displacement (TAPSE)) were used as predictors.
Conclusion. These models can be used to develop a technology for predicting an unfavorable COPD course to ensure a personalized approach when choosing treatment for patients at high risk of exacerbations.
About the Authors
T. V. SychevaRussian Federation
Tatyana V. Sycheva, Ultrasonographer
22 Kalinina Str., Blagoveshchensk, 675000
J. M. Perelman
Russian Federation
Juliy M. Perelman, MD, PhD, DSc (Med.), Professor, Corresponding Member of RAS, Head of Laboratory of Functional Research of Respiratory
System
22 Kalinina Str., Blagoveshchensk, 675000
References
1. Chuchalin A.G., editor. [Respiratory medicine: a manual (Vol.2)]. Moscow: PulmoMedia; 2024 (in Russian).
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2025 report). Available at: https://goldcopd.org/2025-gold-report/
3. MacLeod M., Papi A., Contoli M., Beghé B., Celli B.R., Wedzicha J.A., Fabbri L.M. Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact. Respirology 2021; 26(6):532–551. https://doi.org/10.1111/resp.14041
4. Hogea S.P., Tudorache E., Fildan A.P., Fira-Mladinescu O., Marc M., Oancea C. Risk factors of chronic obstructive pulmonary disease exacerbations. Clin. Respir. J. 2020; 14(3):183–197. https://doi.org/10.1111/crj.13129
5. Zhang J., Chen F., Wang Y., Chen Y. Early detection and prediction of acute exacerbation of chronic obstructive pulmonary disease // Chin. Med. J. Pulm. Crit. Care Med. 2023; 1(2):102–107. https://doi.org/10.1016/j.pccm.2023.04.004
6. Koç Ç., Şahin F. What are the most effective factors in determining future exacerbations, morbidity weight, and mortality in patients with COPD attack? Medicina (Kaunas) 2022; 58(2):163. https://doi.org/10.3390/medicina58020163
7. Yin S., Xu K., Wu S., Liu H., Ding Z. Predictive value of serum interleukin-33 and thymic stromal lymphopoietin for the risk of acute exacerbation in patients with chronic obstructive pulmonary disease. Front. Med. (Lausanne) 2025; 12:1592734. https://doi.org/10.3389/fmed.2025.1592734
8. Müllerová H., Shukla A., Hawkins A., Quint J. Risk factors for acute exacerbations of COPD in a primary care population: A retrospective observational cohort study. BMJ Open 2014; 4(12):e006171. https://doi.org/10.1136/bmjopen-2014-006171
9. Labaki W.W., Xia M., Murray S., Curtis J.L., Barr R.G., Bhatt S.P., Bleecker E.R., Hansel N.N., Cooper C.B., Dransfield M.T., Wells J.M., Hoffman E.A., Kanner R.E., Paine R.3rd, Ortega V.E., Peters S.P., Krishnan J.A., Bowler R.P., Couper D.J., Woodruff P.G., Martinez F.J., Martinez C.H., Han M.K. NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort. Respir. Med. 2018; 140:87–93. https://doi.org/10.1016/j.rmed.2018.06.005
10. Sychova T.V., Perelman J.M. [Echocardiographic characteristics of cardiac function in patients with exacerbation of chronic obstructive pulmonary disease in the dynamics]. Bûlleten' fiziologii i patologii dyhaniyâ = Bulletin Physiology and Pathology of Respiration 2025; 95:26–39 (in Russian). https://doi.org/10.36604/1998-5029-2025-95-26-39
11. Nikolaev N.A., Skirdenko Yu.P. [Russian universal questionnaire for quantitative assessment of adherence to treatment (COP-25)]. Klinicheskaya farmakologiya i terapiya = Clinical pharmacology and therapy 2018; 27(1):74–78 (in Russian).
12. Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F.3rd, Dokainish H., Edvardsen T., Flachskampf F.A., Gillebert T.C., Klein A.L., Lancellotti P., Marino P., Oh J.K., Popescu B.A., Waggoner A.D. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J. Am. Soc. Echocardiogr. 2016; 29(4):277–314. https://doi.org/10.1016/j.echo.2016.01.011
13. Rudski L.G., Lai W.W., Afilalo J., Hua L., Handschumacher M.D., Chandrasekaran K., Solomon S.D., Louie E.K., Schiller N.B. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American So ciety of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 2010; 23(7):685-713. https://doi.org/10.1016/j.echo.2010.05.010
14. Kolosov V.P., Perelman J.M., Ulyanychev N.V. [Methodological approaches to the development of forecasting technologies in pulmonology]. Bûlleten' fiziologii i patologii dyhaniyâ = Bulletin Physiology and Pathology of Respiration. 2006; 22:20–23 (in Russian).
Review
For citations:
Sycheva T.V., Perelman J.M. Predicting the risk of frequent exacerbations in patients with chronic obstructive pulmonary disease. Bulletin Physiology and Pathology of Respiration. 2025;(98):68-74. (In Russ.) https://doi.org/10.36604/1998-5029-2025-98-68-74






















